HomeAbout
About
Acceptance rate:
37%
Time to first decision with review:
37 days*
Impact Factor (JCR):
2.1
Time from acceptance to publication:
23 days*
Total content views:
57,065
Aims and scope
BMJ Neurology Open is an online, peer-reviewed, open access journal, dedicated to publishing research in all areas of clinical neurology and neuroscience. This journal is particularly interested in addressing common diseases and their treatment, or illuminating mechanisms of disease or modes of action of treatments, whether related to their efficacy or their complications. BMJ Neurology Open is also interested in clinical neurology implementation studies which look at how neurological advances can be brought to the patients who need them.
BMJ Neurology Open is the open access companion journal to JNNP and co-owned by the Australian and New Zealand Association of Neurologists (ANZAN).
Editorial Board
For information about the BMJ Neurology Open Editor-in-Chief Prof Richard Gerraty and the rest of the editorial team, please refer to the Editorial Board page.
Ownership
BMJ Neurology Open is co-owned by the Australian and New Zealand Association of Neurologists and BMJ.
Journal information
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Online ISSN
2632-6140
Publication Model
Open access
Frequency
Continuous online publication
Launch date
2019
Indexed by
Web of Science Core Collection: Emerging Sources Citation Index, PubMed Central, DOAJ, Google Scholar, Scopus, Embase (Excerpta Medica)
Journal Statistics 2024
Acceptance rate: 37%
Speed
Time to first decision with review (median): 37 days
Time to first decision without review (median): 5 days
Time from acceptance to publication (median): 23 days
Impact
Impact Factor category: Clinical Neurology
Impact Factor (JCR): 2.1
5 year Impact Factor: 2.5
Journal Citation Indicator: 0.63
Eigenfactor: 0.00077
Citescore: 3.2
Citescore rank: 220/400
Scimago Journal Rank (SJR): 0.753
Reach
Total content views: 57,065
Total Altmetric mentions: 264
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Contact information
For all contact information please refer to the Contact Us page.
For Authors
Please refer to the Instructions for Authors.
To advertise
Rights and permissions
Affiliations
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.